Meet the finalists for the 2025 Edward J. Bobit Fleet Manager of the Year, now in its 40th year. Judges also named.

Bacteria are ubiquitous microscopic organisms capable of rapid growth. While beneficial strains like lactic acid bacteria ...

Today, these microbial partners work in the soil across millions of acres of farmland worldwide, helping farmers grow more ...

Radiolabeled bioactive compounds play a pivotal role in modern nuclear medicine, enabling precise non-invasive imaging and ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

The global biopesticides market size is expected to witness potential gains in the future, and register a significant CAGR of 15.92% over the forecast period. BURLINGAME, CA, UNIT ...

ORCHARD (ClinicalTrials.gov identifier: NCT03944772) is a phase II, biomarker-directed platform study designed to characterize resistance mechanisms and evaluate novel drug combinations in patients ...

Spearhead Bio Offers Precise Plant Engineering Using CRISPR-Directed Jumping Genes May 15, 2025 ...

The approval for pembrolizumab for advanced melanoma was based on the phase 3 KEYNOTE-006 trial, which found that the overall survival rate at 33 months was 50% vs 39% in patients on pembrolizumab ...

Bayer has begun a phase 1 clinical trial for BAY3498264, an investigational oral selective SOS1 inhibitor, to assess its safety and efficacy in patients with advanced KRAS G12C-mutated solid tumours.

Cellino Biotech, which was founded in 2017, won a federal grant worth up to $25 million to continue to develop its advanced biomanufacturing technology. Dubbed NEBULA, the system aims to scale the ...